Neutrophil C5a receptor and the outcome in a rat model of sepsis

This publication has 47 references indexed in Scilit:

• Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist
  British Journal of Pharmacology, 2001
• Altered Expression of CD88 and Associated Impairment of Complement 5a–Induced Neutrophil Responses in Human Immunodeficiency Virus Type 1–Infected Patients with and without Pulmonary Tuberculosis
  The Journal of Infectious Diseases, 2001
• Protective effects of anti‐C5a peptide antibodies in experimental sepsis
  The FASEB Journal, 2001
• Molecular Cloning and Characterization of a Novel Human CC Chemokine, SCYA26
  Genomics, 1999
• The C terminus of the human C5a receptor (CD88) is required for normal ligand‐dependent receptor internalization
  European Journal of Immunology, 1997
• The Human Chemoattractant Complement C5a Receptor Inhibits Cyclic AMP Accumulation Through Gi and Gz Proteins
  Biochemical and Biophysical Research Communications, 1995
• POSTINJURY NEUTROPHIL PRIMING AND ACTIVATION STATES
  Shock, 1995
• Decreased polymorphonuclear leukocyte exudation in critically ill anergic patients associated with increased adhesion receptor expression
  Critical Care Medicine, 1993
• The systemic inflammatory response syndrome (SIRS): Immunology and potential immunotherapy
  Infection, 1993
• Different sensitivities of the responses of human neutrophils stimulated with immune complex and C5a anaphylatoxin to pertussis toxin
  FEBS Letters, 1988